| 1 |
34702273 | Celastrol-based nanomedicine promotes corneal allograft survival. | 2021 Oct 26 |
2 |
| 2 |
29667734 | Celastrol reverses palmitic acid (PA)-caused TLR4-MD2 activation-dependent insulin resistance via disrupting MD2-related cellular binding to PA. | 2018 Oct |
4 |
| 3 |
30015859 | Effect of celastrol on toll‑like receptor 4‑mediated inflammatory response in free fatty acid‑induced HepG2 cells. | 2018 Oct |
4 |
| 4 |
30220146 | [Influence of celastrol on toll-like receptor 4-mediated signaling pathway in the free fatty acids-induced HepG2 cells]. | 2018 Aug 28 |
2 |
| 5 |
27181127 | Celastrol targets IRAKs to block Toll-like receptor 4-mediated nuclear factor-κB activation. | 2016 May |
1 |
| 6 |
24157922 | Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation. | 2014 |
3 |
| 7 |
22949384 | Celastrol attenuates adipokine resistin-associated matrix interaction and migration of vascular smooth muscle cells. | 2013 Feb |
6 |
| 8 |
23861949 | Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4/NF-κB-mediated matrix metalloproteinase-9 expression. | 2013 |
4 |